The exosome diagnostic and therapeutic market in North America is expected to grow from US$ 17,578.32 thousand in 2019 to US$ 154,116.95 thousand by 2027. This represents a CAGR of 32.5% from 2020 to 2027.
The growth of the market in the region is expected to grow owing to increased demand for the use of exosomes as biomarkers in the diagnosis of cancer, increasing prevalence of cancer, aging population and lifestyle changes. Additionally, robust product pipeline, presence of major players and well-developed regulatory policies are projected to drive the North American exosome diagnostic and therapeutic market during the forecast period.
The US has observed fast growth in the exosome diagnostic and therapeutic market within the past few years and is expected to lead the market in North America during the forecast period. Currently, exosomes are rapidly gaining momentum in accessing therapeutic effects of stem cells. Additionally, they hold great promise for use as biomarkers in non-invasive tests, vehicles for drug delivery, and active agents in cosmeceutical products. Investment has also increased in manufacturing technologies to support the production of clinical-grade stem cell exosomes. For instance, in 2017, RoosterBio and Exopharm collaborated on a Stem Cell Exomere Program. The objective of the project is to develop therapeutic extracellular exosomes derived from adult stem cells into clinical practice. Licensing activity has also increased in the industry offering lucrative opportunities for the growth of the market in the US. Further, in 2014, Capricor Therapeutics added seven new patent applications with Cedars-Sinai Medical Center for technologies related to cardiosphere-derived cells (CDCs) and CDC-derived extracellular vesicles, including exosomes.
NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC – MARKET SEGMENTATION
North America Exosome Diagnostic and Therapeutic Market - By Application
North America Exosome Diagnostic and Therapeutic Market - By Product
North America Exosome Diagnostic and Therapeutic Market - By End User
North America Exosome Diagnostic and Therapeutic Market - By Country
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 17,578.32 thousand |
| Market Size by 2027 | US$ 154,116.95 thousand |
| CAGR (2020 - 2027) | 32.5% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Application
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
The North America Exosome Diagnostic and Therapeutic Market is valued at US$ 17,578.32 thousand in 2019, it is projected to reach US$ 154,116.95 thousand by 2027.
As per our report North America Exosome Diagnostic and Therapeutic Market, the market size is valued at US$ 17,578.32 thousand in 2019, projecting it to reach US$ 154,116.95 thousand by 2027. This translates to a CAGR of approximately 32.5% during the forecast period.
The North America Exosome Diagnostic and Therapeutic Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Exosome Diagnostic and Therapeutic Market report:
The North America Exosome Diagnostic and Therapeutic Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Exosome Diagnostic and Therapeutic Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Exosome Diagnostic and Therapeutic Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Exosome Diagnostic and Therapeutic Market
